FCGR2A (muIV.3) Recombinant Monoclonal Antibody

說明書

中文名稱：

FCGR2A (muIV.3) Recombinant Monoclonal Antibody
貨號(hào)：

CSB-RA008540MA1HU
規(guī)格：

￥1320
圖片：
The Binding Activity of Human FCGR2A with Anti-FCGR2A Recombinant antibody
Activity: Measured by its binding ability in a functional ELISA. Immobilized Human FCGR2A (CSB-MP008540HU1) at 2 μg/mL can bind Anti-FCGR2A recombinant antibody. The EC₅₀ is 24.44-32.57 ng/mL.
其他：

產(chǎn)品詳情
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

Uniprot No.：

P12318
基因名：

FCGR2A
別名：

CD32 antibody; CD32 antigen antibody; CDw32 antibody; Fc fragment of IgG; low affinity IIa; receptor (CD32) antibody; Fc fragment of IgG; low affinity IIa; receptor for (CD32) antibody; Fc gamma RII a antibody; Fc gamma RIIa antibody; Fc-gamma RII-a antibody; Fc-gamma-RIIa antibody; FCG2 antibody; FCG2A_HUMAN antibody; FcGR antibody; FCGR2 antibody; FCGR2A antibody; FCGR2A1 antibody; FcRII a antibody; FcRII-a antibody; IGFR2 antibody; IgG Fc receptor II a antibody; IgG Fc receptor II-a antibody; Immunoglobulin G Fc receptor II antibody; low affinity immunoglobulin gamma Fc region receptor II a antibody; Low affinity immunoglobulin gamma Fc region receptor II-a antibody
反應(yīng)種屬：

Human
免疫原：

Recombinant Human FCGR2A protein
免疫原種屬：

Homo sapiens (Human)
標(biāo)記方式：

Non-conjugated
克隆類型：

Monoclonal
抗體亞型：

hIgG1
純化方式：

Affinity-chromatography
克隆號(hào)：

5H2
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA

推薦稀釋比：

Application	Recommended Dilution
ELISA	1:5000-1:50000

Protocols：

ELISA Protocol
儲(chǔ)存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

功能：

Binds to the Fc region of immunoglobulins gamma. Low affinity receptor. By binding to IgG it initiates cellular responses against pathogens and soluble antigens. Promotes phagocytosis of opsonized antigens.
基因功能參考文獻(xiàn)：
1. The results demonstrate that CD32 expression is a marker of CD4+ T cell activation in HIV+ individuals. PMID: 30013105
2. this study shows that genetic variation of human neutrophil Fcgamma receptors and SIRPalpha in antibody-dependent cellular cytotoxicity towards cancer cells PMID: 28952147
3. this study shows that FCGR genetic polymorphism affects antibody responses to GARP in patients with breast cancer PMID: 29879453
4. Data indicate that the Fc gamma receptor FCgammaRIIA polymorphisms did not significantly influence response to rituximab in immune thrombocytopenic purpura (ITP). PMID: 28856973
5. Results showed significantly higher frequency of FC gamma receptor FCGR3A-158V allele in patients with immune thrombocytopenia (ITP) compared with control subjects, but not significant differences in the genotype distribution or allele frequencies for FC gamma receptor FCGR2A-131H/R between patients and controls. PMID: 28942727
6. Differently oxidized isolated subspecies can lead both to stronger as well as weaker binding and activation of the histidine variant of Fc fragment of IgG receptor IIa (FcgammaRIIa). PMID: 28988621
7. CRP bound to surface CD32 (also known as FcgammaRII) on myeloma cells, which activated a pathway mediated by the kinase p38 MAPK and the transcription factor Twist that enhanced the cells' secretion of osteolytic cytokines. PMID: 29233917
8. FCGR2A single nucleotide polymorphism confers susceptibility to idiopathic nephrotic syndrome PMID: 29155175
9. alphaIIb beta3 antagonist TMV-7/trimucrin prevents thrombosis with causing Fc receptor gamma-chain IIa-mediated thrombocytopenia. PMID: 28815933
10. The expression levels of human FcgammaRIIB but not FcgammaRIIA were negatively correlated with serum levels of IgE in human asthma patients. PMID: 29597194
11. When higher-affinity genotypes for FCGR2A, FCGR3A, and FCGR2C were considered together, they were associated with significantly increased tumor shrinkage and prolonged survival in response to HD-IL2... this is the first study to show associations of FCGR genotypes with outcome following HD-IL2 treatment PMID: 27742794
12. FcgammaRIIA and FcgammaRIIB both demonstrated increased methylation levels in Kawasaki disease (KD) patients that underwent IVIG treatment. FcgammaRIIA expression influenced the IVIG treatment response of KD patients. The FcgammaRIIA/IIB mRNA expression ratio was greater in KD patients with coronary artery lesion formation. PMID: 27893416
13. FCGR2A rs1801274 G-allele confers susceptibility to Kawasaki disease and Ulcerative colitis PMID: 27270653
14. farletuzumab has enhanced binding to FCGR3A-158V high-affinity receptor and has an enhanced clinical outcome in ovarian cancer patients with low baseline CA125 levels and at least 1 high-affinity allele of FCGR2A or FCGR3A PMID: 29041009
15. inhibition of Abl/Src with bosutinib reduced FcgammaRIIA-mediated glomerular neutrophil accumulation and renal injury in experimental, crescentic anti-GBM nephritis. PMID: 28891817
16. The present study demonstrates that p.His167Arg, a KD-associated FCGR2A variant, acts as a susceptibility gene in males only. Overall, the gender differences associated with FCGR2A in KD provide a new insight into KD susceptibility. PMID: 28886140
17. Data indicate a mechanism in which Toll-like receptors TLR7/8 signaling, through shedding of FcgRIIA, shifts neutrophil function from phagocytosis to a programmed necrosis pathway, neutrophil extracellular trap formation (NETosis). PMID: 28606989
18. Gene copy number variation (CNV) of the PKLR, FCGR2A, FCGR2C, and FCGR3 genes is associated with malaria severity, and our results provide evidence for a role of CNV in host responses to malaria. PMID: 28605553
19. This study demonstrated that no association between FCGR2A polymorphisms in Guillain-Barre Syndrome in a Brazilian population. PMID: 27609290
20. FCGR3A V and FCGR2A R allele carriers show better responsiveness to anti-TNF-alpha therapy--{REVIEW} PMID: 27490376
21. Association between Fc gamma receptor IIA genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya. PMID: 28427365
22. identification of a subpopulation of 0.012% of CD4 T cells that express CD32a and host up to three copies of HIV DNA per cell; this CD32a(+) reservoir was highly enriched in inducible replication-competent proviruses and can be predominant in some participants; that CD32a(+) lymphocytes represent the elusive HIV-1 reservoir may lead to insights that will facilitate the specific targeting and elimination of this reservoir PMID: 28297712
23. Single nucleotide polymorphisms (SNPs) rs2099684 in IgG receptors FCGR2A/FCGR3A can be considered a genetic risk factor for Takayasu arteritis (TA) in the Chinese Han population. PMID: 27769046
24. The mutant homozygote (CC) of the FCGR2A gene (rs1801274) may have a protective role among Chinese patients with UC. PMID: 27984611
25. Review/Meta-analysis: FcgammaRIIa-H131R may modify treatment rituximab response in diffuse large B cell lymphoma. PMID: 28039707
26. FCGR2A and FCGR2C polymorphisms may also contribute to immunocomplexemia present in sarcoidosis. PMID: 26801149
27. The absence of TULA-2 and also the relative level of TULA-2 expression modulates FcgammaRIIA-mediated platelet reactivity and heparin-induced thrombocytopenia in vivo. PMID: 27765766
28. FCGR2A expression is significantly upregulated in human masticatory mucosa during wound healing PMID: 28005267
29. Review/Meta-analysis: Rheumatoid arthritis patients with FCGR2A HH + HR genotype show a poor response to adalimumab. PMID: 27074847
30. Our findings indicate that CD16 158F>V polymorphism may contribute to the increased risk of Idiopathic Thrombocytopenic Purpura, whereas CD32 131H>R polymorphism may not be an important risk factor for Idiopathic Thrombocytopenic Purpura. PMID: 27315784
31. Our observations support the existence of a central FcgammaRIIA-mediated pathway by which human platelets respond to both Gram-negative and Gram-positive bacteria. PMID: 27025455
32. FcgammaRIIA H131 allele and FcgammaRIIA H/H131 genotype were significantly increased in pediatric Guillain-Barre syndrome patients. PMID: 27064330
33. FCGR2A/FCGR3A-related immune disorder might contribute to the etiology of Takayasu arteritis. PMID: 26996483
34. Data indicate no significant difference in the allele or genotype frequencies of the Fcgamma2RA protein (FCGR2A) rs1801274 single nucleotide polymorphism was observed between groups. PMID: 27267995
35. The RR, HR, and HH FCGR2A-131 genotypes were detected in 1 (11 %), 5 (56 %), and 3 (33 %) of patients with disease relapse compared to 25 (21 %), 56 (47 %), and 38 (32 %) of the 119 patients without relapse. PMID: 27376362
36. The data indicate that FcgammaRIIA genotyping can be used as a marker of genetic susceptibility to sepsis. PMID: 26490967
37. FCGR3A and FCGR2A SNPs do not confer differential responsiveness to rituximab. PMID: 26510856
38. Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis. PMID: 26748351
39. R/R genotype of FCGR2A p.R131H and G/G genotype of CCL2 c.-2518 A > G polymorphisms are associated with thrombocytopenia, which is a characteristic laboratory finding in dengue infections. PMID: 26429304
40. Genetic variants of rs6671847 at FCGR2A and rs17085007 at 13q12 conferred a risk of relapse in patients with ulcerative colitis. PMID: 25787843
41. we fail to find the significant association between FCGR2A H131R and clinical outcome in KRAS wild metastatic colorectal cancer individuals with adjuvant cetuximab therapy PMID: 26363448
42. The results show an association between FcgRIIa, TNF-alpha and IL-6 gene single nucleotide polymorphisms and symptom persistence in Dengue patients. PMID: 26429310
43. FCGR2A polymorphisms constitute a risk factor for graft loss following kidney transplantation and that this effect is related to anti-HLA antibodies. PMID: 26429312
44. FcgammaRIIIA/FcgammaRIIA gene polymorphisms and HER-2 may have a role in antibody-dependent cellular cytotoxicity and clinical response to trastuzumab in breast cancer PMID: 26450443
45. The goal of the study was the development of a novel method for Y402H (g.43097C>T) genotyping, the confirmation of its association with AMD in the Greek population and the investigation of the H131R polymorphism in AMD PMID: 25811666
46. These include an FCGR2A/2C chimeric gene that causes a decreased expression PMID: 26133275
47. Genetic variation Fc gamma receptor IIA may contribute to infectious susceptibility in trauma patients. PMID: 26496101
48. this meta-analysis suggested that the H131R polymorphism in the FCGR2A gene might be associated with susceptibility to KD in Asians. PMID: 26125827
49. study found homozygous carriers of the FcgammaRIIA-131R/R allele had higher malaria-specific antibody levels compared to heterozygous carriers of FcgammaRIIA-131R/H alleles and to homozygous carriers of FcgammaRIIA-131H/H alleles; the pre-existing antibody responses were related to reduced subsequent risk of clinical malaria PMID: 25447268
50. Review: discuss role of human FCGR2A in immune processes and thrombosis. PMID: 25900780
顯示更多

收起更多
亞細(xì)胞定位：

Cell membrane; Single-pass type I membrane protein.
組織特異性：

Found on monocytes, neutrophils and eosinophil platelets.
數(shù)據(jù)庫鏈接：

HGNC: 3616

OMIM: 146790

KEGG: hsa:2212

STRING: 9606.ENSP00000271450

UniGene: Hs.352642

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
VDR Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human